SCHEMBL14059866

SCHEMBL14059866

N#Cc1nnc2cc(-c3ccc4c(c3)CC(=O)N4)ccc2c1NCCC1CC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 6/20 0.48
▸ PGR P06401 3/20 0.40
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ CDC7 O00311 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ DBF4 Q9UBU7 1/20 0.38
▸ CTSC P53634 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ CRBN Q96SW2 2/20 0.35
▸ GRIA1 P42261 2/20 0.34
▸ MELK Q14680 1/20 0.34
▸ MET P08581 1/20 0.34
▸ CTSK P43235 1/20 0.34
▸ CACNG8 Q8WXS5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059316 0.93 LRRK2 (0.48) LRRK2CTSCCRBNCTSK
SCHEMBL14059183 0.84 LRRK2 (0.51) LRRK2
SCHEMBL14059777 0.83 LRRK2 (0.67) LRRK2
SCHEMBL14059769 0.82 LRRK2 (0.46) LRRK2
SCHEMBL14059181 0.81 LRRK2 (0.46) LRRK2
SCHEMBL14059647 0.81 LRRK2 (0.46) LRRK2
SCHEMBL17135865 0.80 LRRK2 (0.71) LRRK2
SCHEMBL17135868 0.80 LRRK2 (0.71) LRRK2
SCHEMBL14059450 0.80 LRRK2 (0.43) LRRK2CTSCCTSK
SCHEMBL14059307 0.79 LRRK2 (0.66) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP claimed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO claimed
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP disclosed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO disclosed
Send feedback